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ABSTRACT  
Background: Globally the burden of diabetes is increasing. Self-monitoring of blood glucose 
(SMBG) has been recommended as part of diabetes management, irrespective of treatment, 
for 50 years. There is evidence that SMBG does not clinically improve glycaemic control in all 
patients with non-insulin treated type 2 diabetes (NITT2DM). Funding and practice models are 
influenced by stakeholders, including industry and patient advocacy groups.  Yet how 
Australian HCPs formulate their views regarding SMBG has not been studied.  
Aim:  This research is designed to inform our understanding of the factors that influence 
Australian HCP’s perceived value of SMBG for patients with NITT2DM and to review the 
evidence for SMBG analysing social, political and economic trends influencing 
recommendations.  
Method:  Following a review of evidence and detailed review of policy documents, using a 
Qualitative Descriptive method, qualitative semi-structured interviews were undertaken with 
Australian HCPs to obtain insight into their beliefs and practices relating to SMBG in patients 
with NITT2DM. The perceptions about the value of monitoring, why and how HCPs form these 
views, and the ways they use the results were examined. Moreover, the type and source of the 
education and training of HCPs were identified.  
Results: A qualitative approach thematic analysis of the data resulted in key insights from 25 
interviews with diabetes educators, pharmacists, endocrinologists, general practitioners, 
dietitians and primary care nurses. Seven main themes emerged from the analysis:  (1) The 
perceived value of SMBG in people with diabetes varies within and between health 
professional groups; (2) The information  patients receive about SMBG is limited; (3)  SMBG is 
not a benign activity and can have negative consequences; (4) The health care professionals 
most likely to use the results in a purposeful manner are diabetes educators and dietitians; (5) 
the capacity to provide specialised training to patients is limited; (6) Professional training does 
not address SMBG; and (7) HCPs want impartial information about SMBG. 
Conclusions: This thesis demonstrated that the views of HCPs are varied and largely based on 
inconsistent information, training as well as the influence of marketing, and other key 
stakeholder groups. The consequences of these actions have implications for the health care 
system, provider and patients.  Inconsistent recommendations to patients contribute to 
adverse health care outcomes and rising health care costs.  These findings provide an empirical 
basis to inform educational and policy interventions to help ensure that training and 
recommendations regarding SMBG are standardised and evidence-based. 
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Definition of terminology 
Blood glucose meter: Portable, hand-held, battery operated instruments used in conjunction 
with blood glucose test strips (BGTS) to measure glucose concentration rapidly in a small 
sample of whole blood. 
HbA1c (Haemoglobin A1c or glycosylated haemoglobin): The HbA1c assay reflects glucose 
control over the three months prior to obtaining the blood sample. It is the only measure of 
glycaemic control that has been shown to be associated with long-term complications of 
diabetes. 
Self-monitoring of blood glucose (SMBG): The act of obtaining a blood sample – usually by the 
finger-stick method, placing the sample on a strip that is inserted into the blood glucose meter. 
The meter will give a result usually within several seconds, displaying the current blood glucose 
level.   
Type 1 diabetes mellitus: An autoimmune condition that usually develops in childhood and 
results in the destruction of insulin-producing β-cells in the pancreas and absolute insulin 
deficiency. 
Type 2 Diabetes Mellitus: A chronic condition that commonly develops in late adulthood. Type 
2 diabetes results from increasing insulin resistance, a reduction in β-cell function, and 
declining β-cell mass. 
ADEA: Australian Diabetes Educators Association. The leading Australian organisation for 
health care professionals providing diabetes education and care.  
ADS:  Australian Diabetes Society. The peak medical and scientific body in Australia for 
diabetes consisting of predominantly endocrinologists, basic science researchers and health 
administration members. 
APNA: Australian Practice Nurse Association. The peak professional body for nurses 
working in primary health care including general practice. 
DA: Diabetes Australia. Diabetes Australia is the national body for people affected by all types 
of diabetes and those at risk.   
DAA: Dietitian’s Association of Australia. The national association of the dietetic profession, 
with branches in each state and territory.  
NDSS: National Diabetes Services Scheme. An initiative of the Australian Government and 
administered by Diabetes Australia. The scheme delivers diabetes-related products, 
information and support services to almost 1.1 million Australians with diabetes. 
NPS: National Prescribing Service. NPS MedicineWise is an independent, not-for-profit and 
evidence-based organisation that provides practical tools such as medicines with the aim to 
improve the way health technologies, medicines and medical tests are prescribed and used. 
PBS: Prescription Benefit Scheme. A program of the Australian Government that provides 
subsidised prescription drugs to residents of Australia.  
PSA: Pharmaceutical Society of Australia. PSA is the major provider of continuing professional 
development programmes for pharmacists in Australia. 
RACGP: Royal Australian College of General Practitioners. Australia’s largest professional 
general practice organisation.
